Molecular typing and biological characteristics of pseudomonas aeruginosa isolated from cystic fibrosis patients in Brazil

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 5, 2010, Pages 462-467

  Stehling, Eliana Guedes ^a   Leite, Domingos S ^b   Silveira, Wanderley D ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cystic fibrosis pseudomonas aeruginosa clonal analysis biological characteristics

Indexed keywords

DNA FRAGMENT; ELASTIN; HEMOLYSIN; PROTEINASE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; CYSTIC FIBROSIS; GENOTYPE; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RIBOTYPING;

EID: 78951493336     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702010000500007     Document Type: Article

References (38)

1. Renders N, Römling U, Verbrug H, Van Belkum A. Comparative typing of Pseudomonas aeruginosa, by random amplifi cation of polymorphic DNA or pulsed fi eld gel electrophoresis of DNA macrorestriction fragments. J Clin Microbiol 2001; 34:3190-5.
2. Boat TF, Welch M, Beaudet AL. In the Metabolic Basis of Inherited Diseases. Scriver CL, Beaudet AL, Sly WS & Valle D (eds). McGraw-Hill Inc, New York, 1995. pp. 3799-876.
3. Yoon SS, Coakley R, La GW et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 2006; 116:436-46.
4. Mereghetti L, Marquet-van der Mee N, Loulergue J et al. Pseudomonas aeruginosa from cystic fi brosis patients: study using whole cell RAPD and antibiotic susceptibility. Path Biol (Paris) 1998; 46:319-24.
5. Van Delden C, and Iglewski BH. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis 1998; 4:551-60.
6. Govan JR, Deretic V. Microbial pathogenesis in cystic fi brosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60:539-74.
7. Yahr TL, Hovey AK, Kulich SM, Frank DW. Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene. J Bacteriol 1995; 177:1169-78.
8. Jaffar-Bandjee MC, Lazdunski A, Bally M et al. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fi brosis in patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol 1995; 33:924-29.
9. Konig B, Vasil ML, Konig W. Role of haemolytic and nonhaemolytic phospholipase C from Pseudomonas aeruginosa in interleukin-8 release from human monocytes. J Med Microbiol 1997; 46:471-8.
10. Swiatecka-Urban A, Moreau-Marquis S, Maceachran DP et al. Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells. Amer J Physiol Cell Physiol 2006; 290:C862-C872.
11. Kersulyte D, Struelens MJ, Deplano A, Berg DE. Comparison of arbitrarily primed PCR and macrorestriction (pulsed-fi eld gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fi brosis patients. J Clin Microbiol 1995; 33:2216-9.
12. Liu Y, Davin-Regli A, Bosi C et al. Epidemiological investigation of Pseudomonas aeruginosa nosocomial bacteraemia isolates by PCR-based DNA fi ngerprinting analysis. J Med Microbiol 1996; 45:359-65.
13. Speijer H, Savelkoul PH, Bonten MJ et al. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 1999; 37:3654-61.
14. Wolska K, Szweda P. A comparative evaluation of PCR ribotyping and ERIC-PCR for determining the diversity of clinical Pseudomonas aeruginosa isolates. Pol J Microbiol 2008; 57:157-63.
15. Liu PY, Shi ZY, Lau YJ et al. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J Clin Microbiol 1995; 33:3304-7.
16. Giraldi GL. 1990. Pseudomonas and related genera, pp. 429-441. In A Balows WJ, Hausler Jr KL et al. (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
17. Lee B, Haagensen JA, Ciofu O, Andersen JB, Hoiby N, Molin S. Heterogeneity of biofi lms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fi brosis. J Clin Microbiol 2005; 43:5247-55.
18. Ausubel FM, Brent R, Kingston RE et al. Curr prot in molecul biol. New York, Wiley Interscience 1987.
19. Nociari MM, Catalano M, Centron Garcia D et al. Comparative usefulness of ribotyping, exotoxin A genotyping, and SalI restriction fragment length polymorphism analysis for Pseudomonas aeruginosa lineage assessment. Diagn. Microbiol. Infect. Dis 1996; 24:179-90.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York, Cold Spring Harbour 1989.
21. Tosin I, Silbert S, Sader HS. The use of molecular typing to evaluate the dissemination of antimicrobial resistance among Gram-negative rods in Brazilian hospitals. Braz J Infect Dis 2003; 7:360-9.
22. Ojeniyi B, Petersen US, Hoiby N. Comparison of genome fi ngerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fi brosis patients. Apmis 1993; 101:168-75.
23. Yeh WC, Yang RC, Boyle. Popgene version 1.31 Microsoft Windows- Based freeware for population genetic analysis. Department of Renewable Resources, University of Alberta, Edmonton, AB Canada 1999.
24. Morihara K. Production of elastase and proteinase by Pseudomonas aeruginosa. J Bacteriol 1964; 88:745-57.
25. Wilson ED. Studies in bacterial protease I. the Relation of protease production to the culture medium. J Bacteriol 1930; 20:41-59.
26. Agodi A, Sciacca A, Campanile F et al. Molecular epidemiology of Pseudomonas aeruginosa from cystic fi brosis in Sicily: genome macrorestriction analysis and rapid PCR-ribotyping. New Microbiol 2000; 23:319-27.
27. Bennekov T, Colding H, Ojeniyi B et al. Comparison of ribotyping and genome fi ngerprinting of Pseudomonas aeruginosa isolates from cystic fi brosis patients. J Clin Microbiol 1996; 34:202-4.
28. Curran B, Jonas D, Grundmann H et al. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 2004; 42:5644-9.
29. Yan W, Shi L, Jia WX et al. Evaluation of the biofilmforming ability and genetic typing for clinical isolates of Pseudomonas aeruginosa by enterobacterial repetitive intergenic consensubased PCR. Microbiol Immunol 2005; 49:1057-61.
30. Spencer D. Clinical outcome in relation to care in centres specializing in cystic fi brosis. Cross infection with Pseudomonas aeruginosa is unusual. Brit Med 1999; 318:58.
31. Spencker FB, Haupt S, Claros MC et al. Epidemiologic characterization of Pseudomonas aeruginosa in patients with cystic fi brosis. Clin Microbiol Infect 2000; 6:600-7.
32. Sener B, Koseoglu O, Ozcelik U et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fi brosis. Int J Med Microbiol 2001; 291:387-93.
33. Mahenthiralingam E, Campbell ME, Foster J et al. Random amplifi ed polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fi brosis. J Clin Microbiol 1996; 34:1129-35.
34. Romling U, Fiedler B, Bosshammer J et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fi brosis. J Infect Dis 1994; 170:1616-21.
35. Berka RM, Gray GL, Vasil ML. Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect Immun1981; 34:1071-4.
36. Stehling EG, Silveira WD, Leite DS. Study of biological characteristics of Pseudomonas aeruginosa strains isolated from patients with cystic fi brosis and patients with non-pulmonary infections. Braz J Infect Dis 2008; 12:86-8.
37. Storey DG, Ujack EE, Rabin HR. Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fi brosis. Infect Immun 1992; 60:4687-94.
38. Jagger KS, Bahner DR, Warren RL. Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. J Clin Microbiol 1983; 17:55-9.